EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Investigation of carbapenem-hydrolysing Klebsiella oxytoca strains lacking detectable carbapenemase genes

Hiroshi Teraguchi, Ayaka Oda, Satoyo Wakai, Sayoko Kawakami, Koki Yoshida, Wataru Hayashi, Norikazu Kitamura, Yo Sugawara, Naoya Ohara, Motoyuki Sugai, Koji Yahara, Aki Hirabayashi

Journal of Medical Microbiology · 13.03.2026 · 75 (3)

DOI: 10.1099/jmm.0.002139 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Medical Microbiology, erschienen am 13.03.2026. Verfasst von Hiroshi Teraguchi und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Laboratory, Kindai University Nara Hospital, Nara 630-0293, Japan. Hauptthemen laut MEDLINE: Klebsiella oxytoca, beta-Lactamases, Carbapenems, Bacterial Proteins. Die Arbeit nennt 20 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Japan Agency for Medical Research and Development.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Carbapenemase-producing Enterobacterales (CPE) pose a clinical concern due to limited treatment options and plasmid-mediated spread of carbapenemase genes. The modified carbapenem inactivation method (mCIM) is increasingly used in clinical settings to detect CPE. Gap Statement. Interpretation of mCIM results for isolates with reduced carbapenem susceptibility remains challenging.

Aim

To assess the interpretation of positive mCIM results in Klebsiella oxytoca isolates lacking detectable carbapenemase genes and exhibiting reduced carbapenem susceptibility and to propose a phenotypic testing strategy for accurate evaluation. Methodology. Antimicrobial susceptibility testing with clavulanic or dipicolinic acid supplementation, phenotypic carbapenemase assays, carbapenem hydrolysis assays and whole-genome sequencing (WGS) were conducted on K. oxytoca strains.

Results

K. oxytoca strains were isolated from both blood and urine samples of a patient in a Japanese hospital. Although classified as susceptible by clinical breakpoints, these isolates exhibited reduced susceptibility to carbapenems. Although these strains were mCIM-positive, the zinc-supplemented carbapenem inactivation method did not support the presence of metallo- β -lactamase (MBL) activity. MIC reductions in the presence of CVA were consistent with inhibition of a class A β -lactamase. In contrast, dipicolinic acid supplementation did not reduce the meropenem MIC, ruling out MBL production. Furthermore, WGS revealed that both K. oxytoca strains lacked known carbapenemase genes, with bla OXY-2-4 being the only identifiable β -lactamase gene encoding a class A enzyme. No novel β -lactamase genes were identified; however, an enhanced bla OXY-2-4 expression-associated point mutation was found in the promoter region. Both K. oxytoca strains exhibited carbapenem-hydrolysing activity, although to a lesser extent than that of the MBL-producing strain.

Conclusion

We identified K. oxytoca strains that lacked known carbapenemase genes but that yielded positive mCIM results, possibly due to OXY-2 overproduction. Our study findings emphasize the need for cautious mCIM result interpretation for K. oxytoca and highlight the diagnostic value of combined susceptibility testing with clavulanic and dipicolinic acids to distinguish the underlying resistance mechanisms. Combining complementary clinical laboratory tests will enable clarification of the factors underlying mCIM positivity and guide clinical decision-making.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Klebsiella oxytocabeta-LactamasesCarbapenemsBacterial ProteinsAnti-Bacterial AgentsHumansMicrobial Sensitivity TestsKlebsiella InfectionsWhole Genome SequencingHydrolysisClavulanic Acid

Stichwörter der Autor:innen

Klebsiella oxytocaMICblaOXY-2clavulanic acidmodified carbapenem inactivation method

Substanzen

beta-LactamasesCarbapenemsBacterial ProteinscarbapenemaseAnti-Bacterial AgentsClavulanic Acid

Autor:innen und Institutionen

  • Department of Clinical Laboratory, Kindai University Nara Hospital, Nara 630-0293, Japan.
  • Dental School, Okayama University, Okayama 700-8558, Japan.
  • Antimicrobial Resistance Research Center, National Institute of Infectious Diseases, Japan Institute for Health Security, Tokyo 189-0002, Japan.
  • Department of Oral Microbiology, Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama University, Okayama 700-8558, Japan.

Förderung

  • Japan Agency for Medical Research and Development

Zitieren

APA

Teraguchi, H., Oda, A., Wakai, S., Kawakami, S., Yoshida, K., Hayashi, W., Kitamura, N., Sugawara, Y., Ohara, N., Sugai, M., Yahara, K., & Hirabayashi, A. (2026). Investigation of carbapenem-hydrolysing Klebsiella oxytoca strains lacking detectable carbapenemase genes. Journal of Medical Microbiology, 75(3). https://doi.org/10.1099/jmm.0.002139

Vancouver

Teraguchi H, Oda A, Wakai S, Kawakami S, Yoshida K, Hayashi W, et al. Investigation of carbapenem-hydrolysing Klebsiella oxytoca strains lacking detectable carbapenemase genes. Journal of Medical Microbiology. 2026;75(3). doi:10.1099/jmm.0.002139

BibTeX
@article{Teraguchi2026,
  author = {Teraguchi, Hiroshi and Oda, Ayaka and Wakai, Satoyo and Kawakami, Sayoko and Yoshida, Koki and Hayashi, Wataru and Kitamura, Norikazu and Sugawara, Yo and Ohara, Naoya and Sugai, Motoyuki and Yahara, Koji and Hirabayashi, Aki},
  title = {Investigation of carbapenem-hydrolysing Klebsiella oxytoca strains lacking detectable carbapenemase genes},
  journal = {Journal of Medical Microbiology},
  year = {2026},
  volume = {75},
  number = {3},
  doi = {10.1099/jmm.0.002139}
}
Kostenlos starten →